Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
50,244,790
-
Shares change
-
+1,031,895
-
Total reported value, excl. options
-
$6,896,982,028
-
Value change
-
+$162,104,322
-
Put/Call ratio
-
95%
-
Number of buys
-
151
-
Number of sells
-
-98
-
Price
-
$137.35
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q3 2017
307 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q3 2017.
BLUEBIRD BIO INC - COM (BLUE) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,244,790 shares
.
Largest 10 shareholders include FMR LLC (6,838,407 shares), Capital Research Global Investors (5,584,617 shares), BAILLIE GIFFORD & CO (5,320,202 shares), WELLINGTON MANAGEMENT GROUP LLP (4,091,117 shares), VANGUARD GROUP INC (3,683,881 shares), BlackRock Inc. (3,599,674 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,736,626 shares), STATE STREET CORP (1,490,128 shares), Capital World Investors (1,133,755 shares), and OppenheimerFunds, Inc. (968,161 shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.